FLT3 and neoplasm: Low levels of Fms-related tyrosine kinase 3 ligand are associated with poor prognosis of tumors.[34] A recent study has pointed out that Fibroblast growth factor 19 (FGR19) can induce angiogenesis, thereby promoting tumor progression.[35]